Drug Shortage Report for TARO-VALSARTAN
| Report ID | 75289 |
| Drug Identification Number | 02363119 |
| Brand name | RAN-VALSARTAN |
| Common or Proper name | RAN-VALSARTAN |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | VALSARTAN |
| Strength(s) | 160MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-02-05 |
| Estimated end date | 2021-02-28 |
| Actual end date | 2021-04-27 |
| Shortage status | Resolved |
| Updated date | 2021-05-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.